FindTrial
Sign In

Local Measures to Prevent Diabetes in the Værnes Region.

The VEND RISK-study. Preventing Diabetes Type 2 in Overweight Persons in the Værnes Region, Central-Norway.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01135901
Acronym
VEND-RISK
Enrollment
180
Registered
2010-06-03
Start date
2010-04-30
Completion date
2018-12-01
Last updated
2020-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus Type 2, Obesity

Keywords

prevention, public health, community health services, Norway

Brief summary

This is a development project involving four different municipalities in Central Norway. The aim is to identify adults with overweight and with an increased risk of developing diabetes mellitus type 2, then to prevent the disease to develop by the means of a behaviour change programme. The programme is group based.

Interventions

BEHAVIORALBehavioural change programme

The programme consists of a introductory course, organised physical activity 2-3 times a week, meetings every 3rd month with lectures and theme nights, and organising self-help groups.

Sponsors

Norwegian University of Science and Technology
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Living in Central Norway * Find Risc score \> 15 * Written, informed consent

Exclusion criteria

* Severe mental disorder * Not being able to function in the group programme

Design outcomes

Primary

MeasureTime frame
Diabetes mellitus type 2Visit 1 (baseline) till Visit 9 (5 years)

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 12, 2026